Stay updated with breaking news from Gamida Cell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Gamida Cell Ltd. , a cell therapy pioneer working to turn cells into powerful therapeutics, today announced that the company will host a conference call and live audio webcast on Monday, May 15,... | June 15, 2023
Gamida Cell (NASDAQ:GMDA – Get Rating) had its target price upped by HC Wainwright from $5.00 to $11.00 in a report issued on Wednesday morning, The Fly reports. HC Wainwright currently has a buy rating on the stock. HC Wainwright also issued estimates for Gamida Cell’s Q1 2023 earnings at ($0.29) EPS, Q2 2023 earnings […]
(This story has not been edited by THE WEEK and is auto-generated from a PTI
Gamida Cell (NASDAQ:GMDA – Get Rating) had its target price lifted by HC Wainwright from $5.00 to $11.00 in a research note published on Wednesday, The Fly reports. HC Wainwright currently has a buy rating on the stock. HC Wainwright also issued estimates for Gamida Cell’s Q1 2023 earnings at ($0.29) EPS, Q2 2023 earnings […]
Gamida Cell (NASDAQ:GMDA – Get Rating) had its price target cut by Needham & Company LLC from $8.00 to $6.00 in a report issued on Thursday, The Fly reports. They currently have a buy rating on the stock. Other analysts also recently issued research reports about the company. HC Wainwright lifted their price objective on […]